ISR
Isoray, Inc.
Halal Rating :
Last Price
$3.44
Last updated:
Market Cap
-
7D Change
1.03%
1 Year Change
629.14%
Company Overview
Exchange
Next Earnings Date
Isoray, Inc. is a medical technology company that develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The company's primary product is Cesium-131, a radioisotope used in internal radiation therapy primarily for prostate cancer treatment.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $369000.0 | $19.07m | - | $69000.0 | 0.00% | 0.36% |
| June 30, 2024 | $526000.0 | $14.81m | - | $23000.0 | 0.00% | 0.16% |
| March 31, 2024 | $325000.0 | $13.36m | - | $29000.0 | 0.00% | 0.22% |
Company Impact
Help us evaluate Isoray, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.